International - The Aurum Institute

New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries

Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five. 24 March 2020 (Johannesburg, South ...
Meet our new Group Chief Financial Officer Arshad Hassim

Aurum welcomes Mr Arshad Hassim who recently joined us as the Group Chief Financial Officer and an executive director and board member. A a registered Chartered Accountant, he brings over 20 years...
TB prevention must be a priority during COVID-19

Members in Action highlights the many areas of work that our members are championing to ensure a better future in lung health. From our Regions, Scientific Sections and member working groups, to the ...
Aurum staff appointed to Vanderbilt University

The Aurum Institute is proud to announce that 10 senior staff members have been appointed in various adjunct positions at the Department of Medicine in the Vanderbilt University School of Medicine. T...
Aurum welcomes new board members

The Aurum Institute welcomes three new members to its Board of Directors, each bringing a wealth of expertise. Dr Jerry Gule, Yaw Peprah and Paula Fray recently joined the Aurum Board as non-executi...
51st Union World Conference on Lung Health

The Aurum Institute is at the 51st Union World Conference on Lung Health. If you are attending the virtual conference, please join us at the sessions listed below. MEDIA INTERVIEWS AND INFORMA...
Prevention has to be a priority for all diseases, not just the pandemic of the moment

...
The Aurum Institute and IAS to Present the Inaugural Gita Ramjee Prize at HIVR4P // Virtual

Johannesburg, 25 January 2021- The Aurum Institute, in collaboration with the International AIDS Society (IAS), will present the inaugural Gita Ramjee Prize at the upcoming HIV Research for Prevention...
New patient-friendly tuberculosis preventive therapy to be rolled out in five high-burden TB countries at affordable price

• Fixed-dose combination treatments reduce the pill burden from nine to three pills a week for adults and prevent TB in those at highest risk of developing the disease • Ethiopia, Ghana, Kenya, M...
World TB Day- TB treatments are notoriously hard to stick to: shorter regimens offer a breakthrough

This article by Prof Violet Chihota, was originally published in The Conversation Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with...
Watch: IMPAACT4TB Project 3HP rollout

We have carried Tuberculosis (TB) for far too long, we need to move away from a narrow focus on treatment in order to end TB. Despite TB being both a curable and treatable disease, millions of people...
PhD Opportunity

The International Division and Implementation Research Division at the Aurum Institute, the TB Centre and Johns Hopkins University, CHAI, Zimbabwe and KNCV Ethiopia are offering a PhD bursary to suppo...
High risk of Tuberculosis in people living with HIV

The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV. The blood mRNA biomarker differentiate...
New study: Optimising the delivery for tuberculosis preventive treatment

The Aurum Institute is implementing a new study to assess the delivery of TB preventive treatment (TPT) in three countries, to generate critical knowledge to improve TPT uptake, implementation and ou...
Aurum launches TB Preventative Treatment rollout in Ghana

Aurum Institute Ghana, recently launched the rollout of 3HP, a new, less toxic, short-course tuberculosis (TB) prevention therapy (TPT). This is part of the IMPAACT4TB project, implemented by a cons...
New grant to provide an analysis of programmatic treatment of drug-resistant TB

Aurum Senior Researcher Dr Yuri van der Heijden, has received a 5-year grant for a study on drug-resistant TB from the National Institutes of Health (NIH). Van der Heijden, holds a joint appointmen...
Fundação Aurum partners with Mozambican government to help end TB

Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Aurum at 11th IAS Conference on HIV science

Aurum experts recently presented at the 11th International Aids Society (IAS) Conference, which brought together thousands of HIV professionals virtually from 18 to 21 July. On the opening day of the...
Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...